The serine protease corin in cardiovascular biology and disease

Frontiers in Bioscience

Volumn 12, Issue 11, 2007, Pages 4179-4190

  Wu, Qingyu ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ANP; BNP; Cardiac hypertrophy; Corin; Hypertension; Preeclampsia; Review

Indexed keywords

MUS;

CRN PROTEIN, HUMAN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STRUCTURE ACTIVITY RELATION;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; GENE EXPRESSION REGULATION; HUMANS; SERINE ENDOPEPTIDASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34347220108     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2379     Document Type: Article

References (132)

1. Davie EW, K. Fujikawa & W. Kisiel: The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30:10363-10370 (1991)
2. Neurath H: The versatility of proteolytic enzymes. J Cell Biochem 32:35-49 (1986)
3. McGrath MF, M. L. de Bold & A. J. de Bold: The endocrine function of the heart. Trends Endocrinol Metab 16:469-477 (2005) (Pubitemid 41660863)
4. Wu Q, H. C. Kuo & G. G. Deng: Serine proteases and cardiac function. Biochim Biophys Acta 1751:82-94 (2005) (Pubitemid 41033298)
5. Davenport RJ: Worth its salt. Elusive enzyme generates hormone that lowers blood pressure. Sci Aging Knowledge Environ 2005: nf5 (2005)
6. Potter LR: "Corination" of the proANP converting enzyme. Cell Metab 1:88-90 (2005)
7. Yan W, N. Sheng, M. Seto, J. Morser & Q. Wu: Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 274:14926-14935 (1999)
8. Hooper JD, A. L. Scarman, B. E. Clarke, J. F. Normyle & T. M. Antalis: Localization of the mosaic transmembrane serine protease corin to heart myocytes. Eur J Biochem 267:6931-6937 (2000)
9. Tomita Y, D. H. Kim, K. Magoori, T. Fujino & T. T. Yamamoto: A novel low-density lipoprotein receptorrelated protein with type II membrane protein-like structure is abundant in heart. J Biochem (Tokyo) 124:784-789 (1998) (Pubitemid 28488158)
10. Pan J, B. Hinzmann, W. Yan, F. Wu, J. Morser & Q. Wu: Genomic structures of the human and murine corin genes and functional GATA elements in their promoters. J Biol Chem 277:38390-38398 (2002) (Pubitemid 35154695)
11. Bleyl S, L. Nelson, S. J. Odelberg, H. D. Ruttenberg, B. Otterud, M. Leppert & K. Ward: A gene for familial total anomalous pulmonary venous return maps to chromosome 4p13-q12. Am J Hum Genet 56:408-415 (1995)
12. Calderone A, S. Bel-Hadj, J. Drapeau, V. El-Helou, H. Gosselin, R. Clement & L. Villeneuve: Scar myofibroblasts of the infarcted rat heart express natriuretic peptides. J Cell Physiol 207:165-173 (2006)
13. Wu F. & Q. Wu: Corin-mediated processing of proatrial natriuretic peptide in human small cell lung cancer cells. Cancer Res 63:8318-8322 (2003) (Pubitemid 37549484)
14. Hooper JD, J. A. Clements, J. P. Quigley & T. M. Antalis: Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276:857-860 (2001) (Pubitemid 32096501)
15. Szabo R, Q. Wu, R. B. Dickson, S. Netzel-Arnett, T. M. Antalis & T. H. Bugge: Type II transmembrane serine proteases. Thromb Haemost 90:185-193 (2003) (Pubitemid 36992495)
16. Wu Q: Type II transmembrane serine proteases. Curr Top Dev Biol 54:167-206 (2003) (Pubitemid 137639469)
17. Yan W, F. Wu, J. Morser & Q. Wu: Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci U. S. A 97:8525-8529 (2000) (Pubitemid 30639706)
18. Knappe S, F. Wu, M. R. Madlansacay & Q. Wu: Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide. J Biol Chem 279:34464-34471 (2004) (Pubitemid 39318073)
19. Knappe S, F. Wu, M. R. Masikat, J. Morser & Q. Wu: Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem 278:52363-52370 (2003) (Pubitemid 38035826)
20. de Bold AJ, H. B. Borenstein, A. T. Veress & H. Sonnenberg: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94 (1981) (Pubitemid 11184926)
21. Inagami T: Atrial natriuretic factor. J Biol Chem 264:3043-3046 (1989) (Pubitemid 19063354)
22. Koller KJ, & D. V. Goeddel: Molecular biology of the natriuretic peptides and their receptors. Circulation 86:1081-1088 (1992)
23. Levin ER, D. G. Gardner & W. K. Samson: Natriuretic peptides. N Engl J Med 339:321-328 (1998) (Pubitemid 28366422)
24. Potter LR, S. Abbey-Hosch & D. M. Dickey: Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27:47-72 (2006) (Pubitemid 43228238)
25. Wilkins MR, J. Redondo & L. A. Brown: The natriuretic-peptide family. Lancet 349:1307-1310 (1997) (Pubitemid 27192482)
26. John SW, J. H. Krege, P. M. Oliver, J. R. Hagaman, J. B. Hodgin, S. C. Pang, T. G. Flynn & O. Smithies: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681 (1995)
27. John SW, A. T. Veress, U. Honrath, C. K. Chong, L. Peng, O. Smithies & H. Sonnenberg: Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol 271:R109-114 (1996)
28. Lopez MJ, S. K. Wong, I. Kishimoto, S. Dubois, V. Mach, J. Friesen, D. L. Garbers & A. Beuve: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65-68 (1995)
29. Cromlish JA, N. G. Seidah & M. Chretien: A novel serine protease (IRCM-serine protease 1) from porcine neurointermediate and anterior pituitary lobes. Isolation, polypeptide chain structure, inhibitor sensitivity, and substrate specificity with fluorogenic peptide substrates. J Biol Chem 261:10850-10858 (1986) (Pubitemid 17194877)
30. Seidah NG, J. A. Cromlish, J. Hamelin, G. Thibault & M. Chretien: Homologous IRCM-serine protease 1 from pituitary, heart atrium and ventricle: a common prohormone maturation enzyme? Biosci Rep 6:835-844 (1986) (Pubitemid 17222890)
31. Imada T, R. Takayanagi & T. Inagami: Identification of a peptidase which processes atrial natriuretic factor precursor to its active form with 28 amino acid residues in particulate fractions of rat atrial homogenate. Biochem Biophys Res Commun 143:587-592 (1987) (Pubitemid 17045788)
32. Imada T, R. Takayanagi & T. Inagami: Atrioactivase, a specific peptidase in bovine atria for the processing of proatrial natriuretic factor. Purification and characterization. J Biol Chem 263:9515-9519 (1988)
33. Corthorn J, M. Cantin & G. Thibault: Rat atrial secretory granules and pro-ANF processing enzyme. Mol Cell Biochem 103:31-39 (1991)
34. Michener ML, J. K. Gierse, R. Seetharam, K. F. Fok, P. O. Olins, M. S. Mai & P. Needleman: Proteolytic processing of atriopeptin prohormone. Mol Pharmacol 30:552-557 (1986) (Pubitemid 17228898)
35. Moreau T, M. Brillard-Bourdet, J. Chagas & F. Gauthier: Pro-rat atrial natriuretic peptide-mimicking peptides as substrates for rat kallikreins rK2 (tonin) and rK9. Biochim Biophys Acta 1249:168-172 (1995)
36. Wu F, W. Yan, J. Pan, J. Morser & Q. Wu: Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J Biol Chem 277:16900-16905 (2002) (Pubitemid 34967716)
37. Chan JC, O. Knudson, F. Wu, J. Morser, W. P. Dole & Q. Wu: Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci U S A 102:785-790 (2005) (Pubitemid 40282743)
38. Chen HH, & J. C. Jr. Burnett: C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32:S22-28 (1998) (Pubitemid 29019748)
39. Wu C, F. Wu, J. Pan, J. Morser & Q. Wu: Furinmediated processing of Pro-C-type natriuretic peptide. J Biol Chem 278:25847-25852 (2003) (Pubitemid 36835344)
40. Thibault G, R. Garcia, J. Gutkowska, J. Bilodeau, C Lazure, N. G. Seidah, M. Chretien, J. Genest & M. Cantin: The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor. Biochem J 241:265-272 (1987) (Pubitemid 17004738)
41. Sei CA, G. L. Hand, S. F. Murray & C. C. Glembotski: The cosecretional maturation of atrial natriuretic factor by primary atrial myocytes. Mol Endocrinol 6:309-319 (1992)
42. Barr PJ: Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66:1-3 (1991) (Pubitemid 121001341)
43. Seidah NG. & M. Chretien: Eukaryotic protein processing: endoproteolysis of precursor proteins. Curr Opin Biotechnol 8:602-607 (1997) (Pubitemid 27455338)
44. Seidah NG. & M. Chretien: Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848:45-62 (1999) (Pubitemid 30001653)
45. Zhou A, G. Webb, X. Zhu & D. F. Steiner: Proteolytic processing in the secretory pathway. J Biol Chem 274:20745-20748 (1999)
46. Lu D, X. Yuan, X. Zheng & J. E. Sadler: Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. J Biol Chem 272:31293-31300 (1997) (Pubitemid 28013261)
47. Lin CY, J. K. Wang, J. Torri, L. Dou, Q. A. Sang & R. B. Dickson: Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization. J Biol Chem 272:9147-9152 (1997) (Pubitemid 27154920)
48. Takeuchi T, J. L. Harris, W. Huang, K. W. Yan, S. R. Coughlin & C. S. Craik: Cellular localization of membranetype serine protease 1 and identification of proteaseactivated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275:26333-26342 (2000)
49. Kurachi K, A. Torres-Rosado & A. Tsuji: Hepsin. Methods Enzymol 244:100-114 (1994)
50. Wu Q: Gene targeting in hemostasis. Hepsin. Front Biosci 6:D192-200 (2001)
51. Yamaguchi N, A. Okui, T. Yamada, H. Nakazato & S. Mitsui: Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord. J Biol Chem 277:6806-6812 (2002) (Pubitemid 34953062)
52. Yamaoka K, K. Masuda, H. Ogawa, K. Takagi, N. Umemoto & S. Yasuoka: Cloning and characterization of the cDNA for human airway trypsin-like protease. J Biol Chem 273:11895-11901 (1998) (Pubitemid 28272097)
53. Cal S, V. Quesada, C. Garabaya & C. Lopez-Otin: Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product. Proc Natl Acad Sci U S A 100:9185-9190 (2003) (Pubitemid 37033904)
54. Lin CY, J. Anders, M. Johnson & R. B. Dickson: Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274:18237-18242 (1999)
55. Kim C, Y. Cho, C. H. Kang, M. G. Kim, H. Lee, E. G. Cho & D. Park: Filamin is essential for shedding of the transmembrane serine protease, epithin. EMBO Rep 6:1045-1051 (2005) (Pubitemid 41637649)
56. Kotkow KJ, S. R. Deitcher, B. Furie & B. C. Furie: The second kringle domain of prothrombin promotes factor Vamediated prothrombin activation by prothrombinase. J Biol Chem 270:4551-4557 (1995)
57. Plow EF, T. Herren, A. Redlitz, L. A. Miles & J. L. Hoover-Plow: The cell biology of the plasminogen system. Faseb J 9:939-945 (1995)
58. Plow EF. & J. Hoover-Plow: The functions of plasminogen in cardiovascular disease. Trends Cardiovasc Med 14:180-186 (2004) (Pubitemid 38942825)
59. Bhanot P, M. Brink, C. H. Samos, J. C. Hsieh, Y. Wang, J. P. Macke, D. Andrew, J. Nathans & R. Nusse: A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225-230 (1996)
60. Finch PW, X. He, M. J. Kelley, A. Uren, R. P. Schaudies, N. C. Popescu, S. Rudikoff, S. A. Aaronson, H. E. Varmus & J. S. Rubin: Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A 94:6770-6775 (1997) (Pubitemid 27281939)
61. Leyns L, T. Bouwmeester, S. H. Kim, S. Piccolo & E. M. De Robertis: Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 88:747-756 (1997) (Pubitemid 27164263)
62. Rattner A, J. C. Hsieh, P. M. Smallwood, D. J. Gilbert, N. G. Copeland, N. A. Jenkins & J. Nathans: A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A 94:2859-2863 (1997) (Pubitemid 27157229)
63. Vinson CR, S. Conover & P. N. Adler: A Drosophila tissue polarity locus encodes a protein containing seven potential transmembrane domains. Nature 338:263-264 (1989)
64. Dann CE, J. C. Hsieh, A. Rattner, D. Sharma, J. Nathans & D. J. Leahy: Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412:86-90 (2001) (Pubitemid 32851515)
65. Novikova EG, S. E. Reznik, O. Varlamov & L. D. Fricker: Carboxypeptidase Z is present in the regulated secretory pathway and extracellular matrix in cultured cells and in human tissues. J Biol Chem 275:4865-4870 (2000) (Pubitemid 30108879)
66. Song L. & L. D. Fricker: Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase. J Biol Chem 272:10543-10550 (1997) (Pubitemid 27181060)
67. Chen Z, Z. Fan, J. E. McNeal, R. Nolley, M. C. Caldwell, M. Mahadevappa, Z. Zhang, J. A. Warrington & T. A. Stamey: Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol 169:1316-1319 (2003) (Pubitemid 36323775)
68. Dhanasekaran SM, T. R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K. J. Pienta, M. A. Rubin & A. M. Chinnaiyan: Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826 (2001) (Pubitemid 32801464)
69. Luo J, D. J. Duggan, Y. Chen, J. Sauvageot, C. M. Ewing, M. L. Bittner, J. M. Trent & W. B. Isaacs: Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61:4683-4688 (2001) (Pubitemid 32691876)
70. Magee JA, T. Araki, S. Patil, T. Ehrig, L. True, P. A. Humphrey, W. J. Catalona, M. A. Watson & J. Milbrandt: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61:5692-5696 (2001) (Pubitemid 32769078)
71. Stamey TA, J. A. Warrington, M. C. Caldwell, Z. Chen, Z. Fan, M. Mahadevappa, J. E. McNeal, R. Nolley & Z. Zhang: Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 166:2171-2177 (2001) (Pubitemid 33065250)
72. Welsh JB, L. M. Sapinoso, A. I. Su, S. G. Kern, J. Wang-Rodriguez, C. A. Moskaluk, H. F. Frierson & G. M. Hampton: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61:5974-5978 (2001) (Pubitemid 32762523)
73. Xuan JA, D. Schneider, P. Toy, R. Lin, A. Newton, Y. Zhu, S. Finster, D. Vogel, B. Mintzer, H. Dinter, D. Light, R. Parry, M. Polokoff, M. Whitlow, Q. Wu & G. Parry: Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res 66:3611-3619 (2006)
74. Burnett JC Jr, P. C. Kao, D. C. Hu, D. W. Heser, D. Heublein, J. P. Granger, T. J. Opgenorth & G. S. Reeder: Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:1145-1147 (1986) (Pubitemid 16016312)
75. Castro LC, C. J. Hobel & J. Gornbein: Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol 171:1642-1651 (1994)
76. Gottlieb SS, M. L. Kukin, D. Ahern & M. Packer: Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13:1534-1539 (1989) (Pubitemid 19145552)
77. Pouta AM, O. J. Vuolteenaho & T. J. Laatikainen: An increase of the plasma N-terminal peptide of proatrial natriuretic peptide in preeclampsia. Obstet Gynecol 89:747-753 (1997) (Pubitemid 27184859)
78. Tran KL, X. Lu, M. Lei, Q. Feng & Q. Wu, Q: Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. Am J Physiol Heart Circ Physiol 287:H1625-1631 (2004) (Pubitemid 39313267)
79. Dries DL, T. P. Cappola, A. Changolkar & K. B. Margulies: Corin, the "pro-ANP/BNP convertase" is upregulated in human heart failure, but inversely correlated with BNP expression. J Cardiac Failure 11:S128 (2005)
80. Jiang W, D. Y. Cai, C. S. Pan, Y. F. Qi, H. F. Jiang, B. Geng & C. S. Tang: Changes in production and metabolism of brain natriuretic peptide in rats with myocardial necrosis. Eur J Pharmacol 507:153-162 (2005) (Pubitemid 40126851)
81. Langenickel TH, I. Pagel, J. Buttgereit, K. Tenner, M. Lindner, R. Dietz, R. Willenbrock & M. Bader: Rat corin gene: molecular cloning and reduced expression in experimental heart failure. Am J Physiol Heart Circ Physiol 287:H1516-1521 (2004) (Pubitemid 39313254)
82. Hunter JJ. & K. R. Chien: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341:1276-1283 (1999) (Pubitemid 29489744)
83. Molkentin JD. & I. G. Dorn: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426 (2001) (Pubitemid 32304323)
84. Olson EN. & R. S. Williams: Calcineurin signaling and muscle remodeling. Cell 101:689-692 (2000)
85. Durocher D. & M. Nemer: Combinatorial interactions regulating cardiac transcription. Dev Genet 22:250-262 (1998) (Pubitemid 28257601)
86. Grepin C, L. Dagnino, L. Robitaille, L. Haberstroh, T. Antakly & M. Nemer: A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol 14:3115-3129 (1994) (Pubitemid 24132725)
87. Molkentin JD, J. R. Lu, C. L. Antos, B. Markham, J. Richardson, J. Robbins, S. R. Grant & E. N. Olson: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228 (1998) (Pubitemid 28180855)
88. Herzig TC, S. M. Jobe, H. Aoki, J. D. Molkentin, A. W. Jr. Cowley, S. Izumo & B. E. Markham: Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci U S A 94:7543-7548 (1997)
89. Shimoyama M, D. Hayashi, E. Takimoto, Y. Zou, T. Oka, H. Uozumi, S. Kudoh, F. Shibasaki, Y. Yazaki, R. Nagai & I. Komuro: Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 100:2449-2454 (1999)
90. Thom T, H. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z. J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, D. Lloyd-Jones, D. C. Jr. Goff, Y. Hong, R. Adams, G. Friday, K. Furie, P. Gorelick, B. Kissela, J. Marler, J. Meias, V. Roger, S. Sidnery, P. Sorlie, J. Steinberger, S. Wasserthiel-Smoller, M. Wilson & P. Wolf: Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85-151 (2006)
91. Nakayama T, M. Soma, Y. Takahashi, D. Rehemudula, K. Kanmatsuse & K. Furuya: Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 86:841-845 (2000) (Pubitemid 30246980)
92. Dries DL, R. G. Victor, J. E. Rame, R. S. Cooper, X. Wu, X. Zhu, D. Leonard, S. I. Ho, Q. Wu, W. Post & M. H. Drazner: Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112:2403-2410 (2005) (Pubitemid 41504489)
93. Fields LE, V. L. Burt, J. A. Cutler, J. Hughes, E. J. Roccella & P. Sorlie: The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44:398-404 (2004) (Pubitemid 39281486)
94. Hajjar I. & T. A. Kotchen: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. Jama 290:199-206 (2003) (Pubitemid 37430058)
95. Campese VM: Why is salt-sensitive hypertension so common in blacks? Nephrol Dial Transplant 12:399-403 (1996)
96. Palacios C, K Wigertz, B. R. Martin, L. Jackman, J. H. Pratt, M. Peacock, G. McCabe & C. M. Weaver: Sodium retention in black and white female adolescents in response to salt intake. J Clin Endocrinol Metab 89:1858-1863 (2004) (Pubitemid 38507945)
97. Pratt JH, W. T. Ambrosius, R. Agarwal, G. J. Eckert & S. Newman: Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension 40:903-908 (2002) (Pubitemid 35434914)
98. Saha C, G. J. Eckert, W. T. Ambrosius, T. Y. Chun, M. A. Wagner, Q. Zhao & J. H. Pratt: Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 46:481-487 (2005) (Pubitemid 41376826)
99. Ambrosius WT, L. J. Bloem, L. Zhou, J. F. Rebhun, P. M. Snyder, M. A. Wagner, C. Guo & J. H. Pratt: Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension 34:631-637 (1999). (Pubitemid 29496445)
100. Baker EH, Y. B. Dong, G. A. Sagnella, M. Rothwell, A. K. Onipinla, N. D. Markandu, F. P. Cappuccio, D. G. Cook, A. Persu, P. Corvol, X. Jeunemaitre, N. D. Carter & G. A. MacGregor: Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet 351:1388-1392 (1998) (Pubitemid 28209996)
101. Cui J, X. Zhou, I. Chazaro, A. L. DeStefano, A. J. Manolis, C. T. Baldwin & H. Gavras: Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. Am J Hypertens 16:859-863 (2003) (Pubitemid 37204684)
102. Bloem LJ, T. M. Foroud, W. T. Ambrosius, M. P. Hanna, D. A. Tewksbury & J. H. Pratt: Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 29:1078-1082 (1997) (Pubitemid 27198213)
103. Dickson ME. & C. D. Sigmund: Genetic basis of hypertension: revisiting angiotensinogen. Hypertension 48:14-20 (2006) (Pubitemid 44297514)
104. Henderson SO, C. A. Haiman & W. Mack: Multiple Polymorphisms in the renin-angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am J Med Sci 328:266-273 (2004) (Pubitemid 39518530)
105. Jain S, X. Tang, C. S. Narayanan, Y. Agarwal, S. M. Peterson, C. D. Brown, J. Ott & A. Kumar: Angiotensinogen gene polymorphism at-217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 277:36889-36896 (2002)
106. Kumar A, Y. Li, S. Patil & S. Jain: A haplotype of the angiotensinogen gene is associated with hypertension in african americans. Clin Exp Pharmacol Physiol 32:495-502 (2005). (Pubitemid 40780282)
107. Rotimi C, A. Puras, R. Cooper, N. McFarlane-Anderson, T. Forrester, O. Ogunbiyi, L. Morrison & R. Ward: Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 27:558-563 (1996) (Pubitemid 26086224)
108. Zhu X. & R. S. Cooper: Linkage disequilibrium analysis of the renin-angiotensin system genes. Curr Hypertens Rep 5:40-46 (2003) (Pubitemid 38898931)
109. Granger JP, B. T. Alexander, W. A. Bennett & R. A. Khalil: Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 14:178S-185S (2001) (Pubitemid 32506713)
110. Lain KY. & J. M. Roberts: Contemporary concepts of the pathogenesis and management of preeclampsia. Jama 287:3183-3186 (2002) (Pubitemid 34686089)
111. Sibai B, G. Dekker & M. Kupferminc: Pre-eclampsia. Lancet 365:785-799 (2005) (Pubitemid 40311367)
112. Gadonski G, B. B. LaMarca, E. Sullivan, W. Bennett, D. Chandler & J. P. Granger: Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48:711-716 (2006) (Pubitemid 44843876)
113. Granger JP, B. T. Alexander, M. T. Llinas, W. A. Bennett & R. A. Khalil: Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9:147-160 (2002) (Pubitemid 135685559)
114. LaMarca BB, W. A. Bennett, B. T. Alexander, K. Cockrell & J. P. Granger: Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46:1022-1025 (2005)
115. Roberts JM, R. N. Taylor, T. J. Musci, G. M. Rodgers, C. A. Hubel & M. K. McLaughlin: Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204 (1989) (Pubitemid 20007682)
116. Davison JM, V. Homuth, A. Jeyabalan, K. P. Conrad, S. A. Karumanchi, S. Quaggin, R. Dechend & F. C. Luft: New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 15:2440-2448 (2004) (Pubitemid 39159344)
117. Eremina V, M. Sood, J. Haigh, A. Nagy, G. Lajoie, N. Ferrara, H. P. Gerber, Y. Kikkawa, J. H. Miner & S. E. Quaggin: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111:707-716 (2003) (Pubitemid 36278589)
118. Levine RJ, S. E. Maynard, C. Qian, K. H. Lim, L. J. England, K. F. Yu, E. F. Schisterman, R. Thadhani, B. P. Sachs, F. H. Epstein, B. M. Sibai, V. P. Sukhatme & S. A. Karumanchi: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683 (2004) (Pubitemid 38364626)
119. Maynard SE, J. Y. Min, J. Merchan, K. H. Lim, J. Li, S. Mondal, T. A. Libermann, J. P. Morgan, F. W. Sellke, I. E. Stillman, F. H. Epstein, V. P. Sukhatme & S. A. Karumanchi: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658 (2003) (Pubitemid 36278583)
120. Redman CW. & I. L. Sargent: Latest advances in understanding preeclampsia. Science 308:1592-1594 (2005) (Pubitemid 40807500)
121. Taylor RN, J. Grimwood, R. S. Taylor, M. T. McMaster, S. J. Fisher & R. A. North: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188:177-182 (2003) (Pubitemid 36135616)
122. Venkatesha S, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y. M. Kim, Y. Bdolah, K. H. Lim, H. T. Yuan, T. A. Libermann, I. E. Stillman, D. Roberts, P. A. D'Amore, F. H. Epstein, F. W. Sellke, R. Romero, V. P. Sukhatme, M. Letarte, S. A. Karumanchi: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642-649 (2006) (Pubitemid 43865232)
123. Molkentin J. D: A friend within the heart: natriuretic peptide receptor signaling. J Clin Invest 111:1275-1277 (2003) (Pubitemid 36554695)
124. Calderone A, C. M. Thaik, N. Takahashi, D. L. Chang & W. S. Colucci: Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101:812-818 (1998) (Pubitemid 28096078)
125. Cao L. & D. G. Gardner: Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25:227-234 (1995)
126. Silberbach M, T. Gorenc, R. E. Hershberger, P. J. Stork, P. S. Steyger & C. T. Jr. Roberts: Extracellular signalregulated protein kinase activation is required for the antihypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem 274:24858-24864 (1999)
127. Horio T, T. Nishikimi, F. Yoshihara, H. Matsuo, S. Takishita & K. Kangawa: Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35:19-24 (2000) (Pubitemid 30054231)
128. Feng JA, G. Perry, T. Mori, T. Hayashi, S. Oparil & Y. F. Chen: Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice. Clin Exp Pharmacol Physiol 30:343-349 (2003) (Pubitemid 36713990)
129. Klinger JR, R. D. Petit, L. A. Curtin, R. R. Warburton, D. S. Wrenn, M. E. Steinhelper, L. J. Field & N. S. Hill: Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol 75:198-205 (1993) (Pubitemid 23221976)
130. Knowles JW, G. Esposito, L. Mao, J. R. Hagaman, J. E. Fox, O. Smithies, H. A. Rockman & N. Maeda: Pressureindependent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107:975-984 (2001) (Pubitemid 32328002)
131. Holtwick R, M. van Eickels, B. V. Skryabin, H. A. Baba, A. Bubikat, F. Begrow, M. D. Schneider, D. L. Garbers & M. Kuhn: Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111:1399-1407 (2003) (Pubitemid 36554711)
132. Rame E, M. H. Drazner, W. Post, R. Peshock, J. Lima, R. S. Cooper & D. L. Dries: Corin I555 (P568) Allele Is Associated With Enhanced Cardiac Hypertrophic Response to Increased Systemic Afterload. Hypertension 49:1-8 (2007)